In conclusion, this systematic review and meta-analysis suggests that the VEGF 936C/T, 1612G/A, −1154G/A, −2549I/D, −460T/C and 405G/C gene polymorphisms are not associated with the risk of RCC. This evidence concerns the gene VEGFA and renal cell carcinoma.